Showing 2,402 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Women

The New Face of HIV and Treating the 'Hardly Reached'

Editor's pick
Medscape (requires free registration)
20 July 2019
Retention & linkage to care

Adults with HIV who have compassionate care providers start and remain in treatment longer

Editor's pick
ScienceDaily
15 July 2019
Injectable & long-acting HIV treatment

ViiV Healthcare announces start of first-ever study to identify and evaluate approaches to implementing its once-monthly injectable HIV treatment in clinical practice

Editor's pick
ViiV Healthcare press release
11 July 2019
Kidney problems

Analysis Backs New Tenofovir’s Kidney Safety Over Old Version

Editor's pick
POZ
11 July 2019
Pharmaceutical industry

GSK touts new Dovato switching data. Is it enough to shake Gilead's HIV lead?

Editor's pick
FiercePharma
11 July 2019
Injectable & long-acting HIV treatment

Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics

Editor's pick
Lyndra Therapeutics press release
10 July 2019
Transgender people

What the Trans Community Needs to Know About New Expert Recommendations

Editor's pick
The Body
8 July 2019
Changing treatment

Drug-Resistance Mutations May Curb Efficacy of Dolutegravir-Based Regimens in Zimbabwe Teens With HIV

Editor's pick
Medscape (free registration required)
7 July 2019
Global health targets

WHO’s “Treat All” Policy Had Immediate Effect on Global HIV Treatment Rates

Editor's pick
POZ
4 July 2019
New & experimental HIV treatments

ViiV Healthcare receives EU marketing authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection

Editor's pick
ViiV press release
3 July 2019
Bad science & bogus treatments

‘You don’t have AIDS’: RT documentary takes on Russia’s top HIV denialist

Editor's pick
Russia Today
1 July 2019
New & experimental HIV treatments

1 Year After Approval: How Does D/C/F/TAF Measure Up?

Editor's pick
Contagion Live
1 July 2019
Transgender people

Once Engaged in Care, Trans Women Have High Rates of HIV Suppression

Editor's pick
POZ
1 July 2019
Vaginal rings & topical PrEP

Novel HIV-1 Inhibitor Shows Promise for Future Treatment of HIV in Women

Editor's pick
Infectious Disease Advisor
26 June 2019
Resistance

Genotype Testing at HIV Diagnosis Provides No Benefit

Editor's pick
Infectious Disease Advisor
25 June 2019
Adherence

Researchers Discuss Ethics and Privacy Concerns About the Growing Field of HIV Adherence Monitoring

Editor's pick
The Body Pro
25 June 2019
Injectable & long-acting HIV treatment

Study Finds Long-Acting HIV Meds Are Acceptable to Many People, but Differences Exist Among Groups

Editor's pick
The Body Pro
25 June 2019
Side effects

Major HIV drug calls for vigilance

Editor's pick
University of Duisberg-Essen
24 June 2019
HIV treatment for children & young people

Biktarvy Approved to Treat Pediatric Patients With HIV-1

Editor's pick
Monthly Prescribing Reference
20 June 2019
New & experimental HIV treatments

CytoDyn Announces Major Discovery for its Monotherapy Indication

Editor's pick
CytoDyn press release
20 June 2019
Cardiovascular disease

Efavirenz Dose Reduction Improves Lipid Profile in Adults With HIV-1

Editor's pick
Infectious Disease Advisor
19 June 2019
Bad science & bogus treatments

Low trust in vaccines 'a global crisis'

Editor's pick
BBC
19 June 2019
New & experimental HIV treatments

CytoDyn: Uncovering An Opportunity

Editor's pick
Seeking Alpha
12 June 2019
Bad science & bogus treatments

2 Chinese Babies With Edited Genes May Face Higher Risk Of Premature Death

Editor's pick
NPR
4 June 2019